Peng Su

3.8k total citations
95 papers, 2.6k citations indexed

About

Peng Su is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peng Su has authored 95 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 34 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Peng Su's work include Ubiquitin and proteasome pathways (15 papers), Hippo pathway signaling and YAP/TAZ (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Peng Su is often cited by papers focused on Ubiquitin and proteasome pathways (15 papers), Hippo pathway signaling and YAP/TAZ (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Peng Su collaborates with scholars based in China, United States and Canada. Peng Su's co-authors include Qifeng Yang, Gengyin Zhou, Hanwen Zhang, Ning Zhang, Bing Chen, Ying Liu, Wenjing Zhao, Xiaofang Zhang, Bao‐Xiang Zhao and Yanru Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peng Su

87 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Su China	29	1.5k	923	742	257	241	95	2.6k
Zhi Yang China	30	1.6k 1.1×	891 1.0×	832 1.1×	330 1.3×	310 1.3×	113	3.0k
Jie Ge China	33	1.4k 0.9×	958 1.0×	551 0.7×	272 1.1×	198 0.8×	113	2.5k
Pin‐I Huang Taiwan	33	1.9k 1.2×	1.1k 1.2×	1.2k 1.6×	329 1.3×	207 0.9×	95	3.4k
Yuanyuan Yang China	29	1.8k 1.2×	535 0.6×	612 0.8×	271 1.1×	199 0.8×	145	3.0k
Yongchang Chen China	23	1.4k 0.9×	465 0.5×	813 1.1×	209 0.8×	411 1.7×	76	2.5k
Zhishan Wang United States	32	2.0k 1.3×	1.0k 1.1×	418 0.6×	321 1.2×	273 1.1×	62	2.8k
Lixia Xu China	30	1.6k 1.1×	966 1.0×	622 0.8×	399 1.6×	258 1.1×	106	2.8k
Rong Shao China	21	981 0.6×	463 0.5×	730 1.0×	255 1.0×	312 1.3×	58	2.3k
Wenyan Xu China	28	1.3k 0.8×	806 0.9×	806 1.1×	425 1.7×	220 0.9×	65	2.2k

Countries citing papers authored by Peng Su

Since Specialization

Citations

This map shows the geographic impact of Peng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Su more than expected).

Fields of papers citing papers by Peng Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Su. The network helps show where Peng Su may publish in the future.

Co-authorship network of co-authors of Peng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Su. A scholar is included among the top collaborators of Peng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Su. Peng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Huijie, Jin Cui, Peng Su, et al.. (2025). Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis. Cancer Research. 85(19). 3752–3770.

Li, Yongzheng, Ming Shi, Zhiyao Fan, et al.. (2024). Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms. Frontiers in Endocrinology. 15. 1281622–1281622.

Gong, Lei, Ping Li, Jingjing Liu, et al.. (2024). A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma. BMC Cancer. 24(1). 244–244. 1 indexed citations

Sun, Yanan, Dongyi Liu, Xiaobo Zhang, et al.. (2024). Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell Death Discovery. 10(1). 365–365. 6 indexed citations

Liang, Yiran, Bing Chen, Long Li, et al.. (2024). LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization. Oncogene. 43(14). 1019–1032. 6 indexed citations

Su, Peng, et al.. (2024). Enhancing Skin Injury Repair: Combined Application of PF-127 Hydrogel and hADSC-Exos Containing miR-148a-3p. ACS Biomaterials Science & Engineering. 10(4). 2235–2250. 9 indexed citations

Zhuang, Ting Ting, Shuqing Zhang, Dongyi Liu, et al.. (2024). USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα. Journal of Experimental & Clinical Cancer Research. 43(1). 249–249. 5 indexed citations

Liu, Ying, Hanwen Zhang, Peng Su, et al.. (2023). Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1. Autophagy. 19(9). 2443–2463. 38 indexed citations

Xiao, Yang, Dehai Wang, Huijie Yang, et al.. (2023). PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα. Oncogene. 43(4). 248–264. 17 indexed citations

10.

Wang, Tianshi, Dehai Wang, Yanan Sun, et al.. (2023). Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 297–297. 14 indexed citations

11.

Zhuo, Shu, Ting Zhuang, Yong Suk Cho, et al.. (2022). YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. Nature Communications. 13(1). 3075–3075. 51 indexed citations

12.

Wang, Yawen, Xu Chen, Yaru Tian, Long Liu, & Peng Su. (2022). Decreased Expression of circ_0000160 in Breast Cancer With Axillary Lymph Node Metastasis. Frontiers in Molecular Biosciences. 8. 690826–690826. 2 indexed citations

13.

Zhang, Wenbo, Feifei Sun, Jing Hu, et al.. (2020). KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 81(4). 1026–1039. 57 indexed citations

14.

Zhang, Hanwen, Ning Zhang, Ying Liu, et al.. (2019). Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer. Cancer Research. 79(13). 3347–3359. 107 indexed citations

15.

Zhan, Hanxiang, Yugang Cheng, Lei Wang, et al.. (2019). Clinicopathological Features and Treatment Outcomes of Solid Pseudopapillary Neoplasms of the Pancreas: A 10-Year Case Series from a Single Center. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(5). 600–607. 16 indexed citations

16.

Qi, Mei, Jing Hu, Meng Jiao, et al.. (2019). CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4. Oncogenesis. 8(3). 23–23. 24 indexed citations

17.

Hu, Jing, Jing Zhang, Feifei Sun, et al.. (2019). Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor. Anti-Cancer Drugs. 30(7). 677–684. 9 indexed citations

18.

Hu, Jing, Peng Su, Meng Jiao, et al.. (2018). TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12. Translational Oncology. 11(2). 416–425. 26 indexed citations

19.

Zhu, Jiang, Xiaoyan Li, Xiangnan Kong, et al.. (2012). Testin is a tumor suppressor and prognostic marker in breast cancer. Cancer Science. 103(12). 2092–2101. 35 indexed citations

20.

Zhang, Xiaofang, Xiaojuan Wu, Peng Su, et al.. (2012). Doxorubicin Influences the Expression of Glucosylceramide Synthase in Invasive Ductal Breast Cancer. PLoS ONE. 7(11). e48492–e48492. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact